Takahiro Sato

Associate Director, Reverse Translation & Innovation, Oncology Emu @GSK

Philadelphia, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2023 — Present

Associate Director, Reverse Translation & Innovation, Oncology Emu @GSK

View department →

Driving reverse translation efforts in GSK oncology

EDUCATION

2003 — 2007

Lehigh University

B.S., Biology

2007 — 2013

Thomas Jefferson University

Doctor of Philosophy (Ph.D.), Molecular Pharmacology and Structural Biology

SKILLS

BiomarkersDrug DiscoveryEpigeneticsRnaseqMolecular BiologyCell CultureDna MethylationCancer ResearchFlow CytometryRChip-SeqBioinformaticsCell BiologyWestern BlottingBiochemistryComputational Biology

ABOUT TAKAHIRO SATO

Motivated scientist with extensive experience applying computational biology to impact…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Takahiro Sato — Associate Director, Reverse Translation & Innovation, Oncology Emu at GSK in Philadelphia, PA, US | Unifers